Life Sciences Leaders Optimistic About Funding Prospects but Cautious About Growth Outlook, New Research Finds
Lowenstein Sandler announced today the release of Funding Life Sciences: Where the Opportunities and Resources Are in 2021 and Beyond , a report based on survey results that gauge the sentiment of executives at life sciences startups and early-stage companies regarding the current state of investment in the sector.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201207005725/en/
Michael J. Lerner (Photo: Business Wire)
Coauthored by Michael J. Lerner , partner and Chair, Life Sciences Group , and Steven M. Skolnick , partner and Chair, Capital Markets and Securities Practice , and Vice Chair, Transactions & Advisory Group , the survey reveals the specific impact that the COVID-19 pandemic has had on the industry, from delaying clinical trials to shifting life sciences leaders' focus to cutting costs and shoring up balance sheet...